| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |